Unknown

Dataset Information

0

Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors.


ABSTRACT: Monoacylglycerol lipase is a serine hydrolase that plays a major role in the degradation of the endocannabinoid neurotransmitter 2-arachidonoylglycerol. A wide number of MAGL inhibitors are reported in literature; however, many of them are characterised by an irreversible mechanism of action and this behavior determines an unwanted chronic MAGL inactivation, which acquires a functional antagonism of the endocannabinoid system. The possible use of reversible MAGL inhibitors has only recently been explored, due to the lack of known compounds possessing efficient reversible inhibitory activities. In this work, we report a new series of terphenyl-2-methyloxazol-5(4H)-one derivatives characterised by a reversible MAGL-inhibition mechanism. Among them, compound 20b showed to be a potent MAGL reversible inhibitor (IC50?=?348?nM) with a good MAGL/FAAH selectivity. Furthermore, this compound showed antiproliferative activities against two different cancer cell lines that overexpress MAGL.

SUBMITTER: Granchi C 

PROVIDER: S-EPMC6009861 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors.

Granchi Carlotta C   Caligiuri Isabella I   Bertelli Eleonora E   Poli Giulio G   Rizzolio Flavio F   Macchia Marco M   Martinelli Adriano A   Minutolo Filippo F   Tuccinardi Tiziano T  

Journal of enzyme inhibition and medicinal chemistry 20171201 1


Monoacylglycerol lipase is a serine hydrolase that plays a major role in the degradation of the endocannabinoid neurotransmitter 2-arachidonoylglycerol. A wide number of MAGL inhibitors are reported in literature; however, many of them are characterised by an irreversible mechanism of action and this behavior determines an unwanted chronic MAGL inactivation, which acquires a functional antagonism of the endocannabinoid system. The possible use of reversible MAGL inhibitors has only recently been  ...[more]

Similar Datasets

| S-EPMC8199291 | biostudies-literature
| S-EPMC6352951 | biostudies-literature
| S-EPMC9303458 | biostudies-literature
| S-EPMC4727773 | biostudies-literature
| S-EPMC6928863 | biostudies-literature
| S-EPMC6711126 | biostudies-literature
| S-EPMC6968640 | biostudies-literature
| S-EPMC6837174 | biostudies-literature
| S-EPMC3426190 | biostudies-literature
| S-EPMC5642020 | biostudies-literature